Novel Factors for Muscle Mass and Strength in Adults
影响成人肌肉质量和力量的新因素
基本信息
- 批准号:9324114
- 负责人:
- 金额:$ 38.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-15 至 2019-04-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAdultAffectAgeAgingAmericanAmino AcidsAntioxidantsAscorbic AcidBlood VesselsBlood flowCarnitineCarotenoidsCharacteristicsCoenzymesCollagenCommunitiesDNA copy numberDataDietElderlyFutureGait speedGoalsHand StrengthHealthImpairmentIndividualInflammationInsulinIntakeInterventionIntervention StudiesKnowledgeLinkMeasuresMediatingMitochondriaMitochondrial DNAModelingMuscleMuscle ProteinsMuscle functionMuscular AtrophyOutcomeOxidative StressParticipantPathway interactionsPerfusionPhysical FunctionPhysical activityPhysiologicalPublic HealthRestRisk FactorsRoleSkeletal MuscleThinnessTimeUpper ExtremityValidationVitamin EWomanWorkage relatedage-related muscle lossarmbasebrachial arterycardiovascular healthcohortcombatdisabilityfall riskfracture riskfrailtyinsightmenmulti-component interventionmuscle formmuscle strengthnoveloffspringpreventprotein intakereduced muscle massresponsetime use
项目摘要
ABSTRACT / PROJECT SUMMARY
Age-related decline in muscle mass and strength is an important public health issue. Future interventions will
depend on identifying the physiologic pathways involved in these muscle changes and consequent physical
function. We propose to investigate novel risk factors and identify associated pathways that affect age-related
declines in muscle mass, quality, strength and gait speed. Our long term goal is to identify novel risk factors
and associated pathways that affect age-related declines in muscle and physical function. The objective is to
determine the roles of antioxidant intake, vascular function and mitochondrial function in loss of muscle mass,
quality, strength and gait speed in adult men and women, providing new public health insights. We hypothesize
that low antioxidant intake, impaired vascular function and lower mitochondrial DNA copy number (mtDNA-CN)
will each contribute towards decreased muscle mass, quality, strength and gait speed, even accounting for
established risk factors. We will address this work via 4 aims using up to 1,912 participants from a well-
characterized cohort, the Framingham Offspring Study. Aim 1 will examine the association of antioxidant
intakes (Vitamin C, Vitamin E and total carotenoids) with measures of muscle mass, quality, strength [defined
as appendicular lean muscle mass/height2, grip strength-to-arm lean mass ratio (arm muscle quality), change
in appendicular lean muscle mass/height2, change in grip strength over time] and change in gait speed. Aim 2
will examine the association of vascular function (assessed by brachial artery resting characteristics,
hyperemic flow response and aortic stiffness with measures of muscle mass, quality, strength and change in
gait speed. Aim 3 will examine the association of mtDNA-CN with measures of muscle mass, quality, strength
and change in gait speed. Finally, Aim 4 will examine the combined effect of the novel risk factors evaluated
from Aims 1-3 along with established risk factors (protein intake, physical activity and inflammation), on
measures of muscle mass, quality, strength and change in gait speed. We plan to validate the findings from
these aims by using a validation cohort, the Cardiovascular Health Study.
The expected outcome is evidence for low antioxidant intake, impaired vascular and low mtDNA-CN as novel
risk factors for age-related decrease in muscle mass, quality, strength and gait speed. The significance of the
proposed work is that it will increase our understanding of individual contributions and combined effect of the
proposed novel risk factors on age-related declines in muscle and physical function. This study will provide a
strong basis for future multi-modality intervention studies aimed at reducing or preventing age-related declines
in muscle and their debilitating consequences among older adults.
1
摘要/项目总结
与肥胖相关的肌肉质量和力量下降是一个重要的公共卫生问题。未来的干预措施将
这取决于识别参与这些肌肉变化的生理途径和随之而来的身体
功能我们建议调查新的危险因素,并确定影响年龄相关性的相关途径。
肌肉质量、质量、力量和步态速度下降。我们的长期目标是确定新的风险因素
以及影响与年龄相关的肌肉和身体功能下降的相关途径。目标是
确定抗氧化剂摄入、血管功能和线粒体功能在肌肉质量损失中的作用,
在成年男性和女性的质量,力量和步态速度,提供新的公共卫生见解。我们假设
抗氧化剂摄入量低,血管功能受损,线粒体DNA拷贝数(mtDNA-CN)降低,
每一个都会导致肌肉质量、质量、力量和步态速度的下降,甚至会导致
确定的风险因素。我们将通过4个目标来解决这项工作,使用来自一口井的多达1,912名参与者-
特征化队列,即Fractionary Offspring研究。目的1将研究抗氧化剂的关联
摄入量(维生素C,维生素E和总类胡萝卜素)与肌肉质量,质量,力量的措施[定义
作为apapapricular瘦肌肉质量/身高2,握力与手臂瘦肌肉质量比(手臂肌肉质量),变化
在apapapricular瘦肌肉质量/高度2,握力随时间的变化]和步态速度的变化。目的2
将检查血管功能(通过肱动脉静息特征评估,
充血性血流反应和主动脉僵硬,测量肌肉质量、质量、强度和
步态速度目的3将研究mtDNA-CN与肌肉质量、质量、力量指标的相关性。
和步态速度的变化。最后,目标4将检查评估的新风险因素的综合影响
从目标1-3沿着以及确定的风险因素(蛋白质摄入、体力活动和炎症),
测量肌肉质量、质量、力量和步态速度的变化。我们计划验证来自
这些目标通过使用一个验证队列,心血管健康研究。
预期结果是证据表明低抗氧化剂摄入、血管受损和低mtDNA-CN是新的
与年龄相关的肌肉质量、质量、力量和步态速度下降的风险因素。的意义
建议的工作是,它将增加我们对个人贡献和综合影响的理解,
提出了与年龄相关的肌肉和身体功能下降的新风险因素。这项研究将提供一个
为未来旨在减少或预防年龄相关衰退的多模式干预研究奠定了坚实的基础
在老年人中的肌肉及其衰弱的后果。
1
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shivani Sahni其他文献
Shivani Sahni的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shivani Sahni', 18)}}的其他基金
A randomized, double-blind, placebo-controlled, clinical trial of a probiotic/prebiotic supplement for the dietary management of age-related bone loss.
益生菌/益生元补充剂用于饮食管理与年龄相关的骨质流失的随机、双盲、安慰剂对照临床试验。
- 批准号:
10733549 - 财政年份:2023
- 资助金额:
$ 38.55万 - 项目类别:
Novel Factors for Muscle Mass and Strength in Adults
影响成人肌肉质量和力量的新因素
- 批准号:
9175681 - 财政年份:2016
- 资助金额:
$ 38.55万 - 项目类别:
Uric Acid, Vitamin C and Bone Health: The Framingham Study
尿酸、维生素 C 和骨骼健康:弗雷明汉研究
- 批准号:
8447230 - 财政年份:2013
- 资助金额:
$ 38.55万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 38.55万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 38.55万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 38.55万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 38.55万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 38.55万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 38.55万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 38.55万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 38.55万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 38.55万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 38.55万 - 项目类别:
Research Grant














{{item.name}}会员




